The 25-year old Dutch Breast Cancer Screening Program continues to satisfy expectations. Success is due to high quality and efficient organization, combined with a solid screening data recording system. The numbers of false-positives and overdiagnosis are less common than in some other countries, while the number of false-negatives is low. Full transparency and confidence about the results and (cost)effectiveness feed the lively effectiveness debate among researchers and in the lay press.